BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34219715)

  • 1. Testing for Interactions Between APOE and Klotho Genotypes on Cognitive, Dementia, and Brain Imaging Metrics in UK Biobank.
    Tank R; Ward J; Celis-Morales C; Smith DJ; Flegal KE; Lyall DM
    J Alzheimers Dis; 2021; 83(1):51-55. PubMed ID: 34219715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
    Lyall DM; Ward J; Ritchie SJ; Davies G; Cullen B; Celis C; Bailey ME; Anderson J; Evans J; Mckay DF; Mcintosh AM; Sattar N; Smith DJ; Deary IJ; Pell JP
    Age Ageing; 2016 Jul; 45(4):511-7. PubMed ID: 27103599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
    Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
    JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effect of APOE ɛ4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults.
    Werhane ML; Thomas KR; Edmonds EC; Bangen KJ; Tran M; Clark AL; Nation DA; Gilbert PE; Bondi MW; Delano-Wood L;
    J Alzheimers Dis; 2018; 62(4):1567-1578. PubMed ID: 29562507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers.
    Belloy ME; Eger SJ; Le Guen Y; Napolioni V; Deters KD; Yang HS; Scelsi MA; Porter T; James SN; Wong A; Schott JM; Sperling RA; Laws SM; Mormino EC; He Z; Han SS; Altmann A; Greicius MD; ; ; ;
    Neurobiol Aging; 2021 May; 101():123-129. PubMed ID: 33610961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM
    Neurobiol Aging; 2019 Apr; 76():162-165. PubMed ID: 30716541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing for interaction between
    Lyall DM; Celis-Morales C; Lyall LM; Graham C; Graham N; Mackay DF; Strawbridge RJ; Ward J; Gill JMR; Sattar N; Cavanagh J; Smith DJ; Pell JP
    Neurology; 2019 Jun; 92(23):e2691-e2698. PubMed ID: 31028125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study.
    He P; Zhou C; Ye Z; Liu M; Zhang Y; Wu Q; Zhang Y; Yang S; Xiaoqin G; Qin X
    Alzheimers Res Ther; 2023 Jan; 15(1):9. PubMed ID: 36624486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank.
    Folley S; Zhou A; Llewellyn DJ; Hyppönen E
    J Alzheimers Dis; 2019; 71(3):741-750. PubMed ID: 31450492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study.
    Klinedinst BS; Le ST; Larsen B; Pappas C; Hoth NJ; Pollpeter A; Wang Q; Wang Y; Yu S; Wang L; Allenspach K; Mochel JP; Bennett DA; Willette AA
    J Alzheimers Dis; 2020; 78(3):1245-1257. PubMed ID: 33252089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
    Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
    Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden.
    Bäckman K; Joas E; Waern M; Östling S; Guo X; Blennow K; Skoog I; Gustafson DR
    J Alzheimers Dis; 2015; 48(4):1119-27. PubMed ID: 26402098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    Han SH; Noh DH; Jo EJ; Kam KY
    J Alzheimers Dis; 2022; 87(3):1181-1188. PubMed ID: 35466935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
    Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
    J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.